Comparison of Receptor-Defined Breast Cancer Subtypes Between German and Sudanese Women: A Facility-Based Cohort Study

Purpose: The objective of this study was to compare tumor characteristics, biomarkers, and surrogate subtypes of breast cancer between Sudanese and German women. Methods: Tumor characteristics and immunohistochemistry markers (estrogen receptor [ER], progesterone receptor [PR], and human epidermal g...

Full description

Bibliographic Details
Main Authors: Asmerom Tesfamariam Sengal, Nada Suliman Haj Mukhtar, Martina Vetter, Ahmed Mohammed Elhaj, Shahinaz Bedri, Steffen Hauptmann, Christoph Thomssen, Ahmed Abdalla Mohamedani, Claudia Wickenhauser, Eva Johanna Kantelhardt
Format: Article
Language:English
Published: American Society of Clinical Oncology 2017-08-01
Series:Journal of Global Oncology
Online Access:http://ascopubs.org/doi/10.1200/JGO.2017.010082
_version_ 1818178048710672384
author Asmerom Tesfamariam Sengal
Nada Suliman Haj Mukhtar
Martina Vetter
Ahmed Mohammed Elhaj
Shahinaz Bedri
Steffen Hauptmann
Christoph Thomssen
Ahmed Abdalla Mohamedani
Claudia Wickenhauser
Eva Johanna Kantelhardt
author_facet Asmerom Tesfamariam Sengal
Nada Suliman Haj Mukhtar
Martina Vetter
Ahmed Mohammed Elhaj
Shahinaz Bedri
Steffen Hauptmann
Christoph Thomssen
Ahmed Abdalla Mohamedani
Claudia Wickenhauser
Eva Johanna Kantelhardt
author_sort Asmerom Tesfamariam Sengal
collection DOAJ
description Purpose: The objective of this study was to compare tumor characteristics, biomarkers, and surrogate subtypes of breast cancer between Sudanese and German women. Methods: Tumor characteristics and immunohistochemistry markers (estrogen receptor [ER], progesterone receptor [PR], and human epidermal growth factor receptor 2 [HER2]) were collected from the routine assessment of consecutive patients with invasive breast cancer diagnosed from 2010 to 2015 (Gezira University Pathology Laboratory, Gezira, Sudan) and from 1999 to 2013 (Breast Centre, Martin-Luther-University, Halle, Germany). Results: A total of 2,492 patients (German [n = 1,932] and Sudanese [n = 560]) were included. Age at diagnosis ranged from 20 to 94 years. Sudanese women were, on average, 10 years younger than German women, with a mean (± standard deviation) age of 48.8 (13.5) and 58.6 (12.4) years, respectively. The Sudanese women had a higher grade, larger tumor, and more lymph node positivity compared with German women. ER-, PR-, and HER2-negative proportions were 55%, 61.8%, and 71.3%, respectively, for Sudanese women versus 22.7%, 32.3%, and 82.5%, respectively, for German women. The triple-negative subtype was more prevalent in Sudanese women (34.5%) than in German women (14.2%). The strongest factor associated with ER-negative disease was grade III (odds ratio, 19.6; 95% CI 11.6 to 33.4; P < .001). Sudanese patients were at higher risk for ER-negative breast cancer, with an odds ratio of 2.01 (P = .001; adjusted for age, size, nodal status, histologic type, and grade). Stratified by grade, the influence of origin was observed in grade I and grade II tumors, but not in grade III tumors. Conclusion: Sudanese women had more aggressive tumor characteristics and unfavorable prognostic biomarkers. After adjustment, Sudanese origin was still associated with hormone receptor–negative disease, especially in grade I and II tumors. These findings suggest differences in tumor biology among these ethnic groups.
first_indexed 2024-12-11T20:41:47Z
format Article
id doaj.art-2e23a3efacf74a54920991a133c7e2cc
institution Directory Open Access Journal
issn 2378-9506
language English
last_indexed 2024-12-11T20:41:47Z
publishDate 2017-08-01
publisher American Society of Clinical Oncology
record_format Article
series Journal of Global Oncology
spelling doaj.art-2e23a3efacf74a54920991a133c7e2cc2022-12-22T00:51:29ZengAmerican Society of Clinical OncologyJournal of Global Oncology2378-95062017-08-01411210.1200/JGO.2017.01008218Comparison of Receptor-Defined Breast Cancer Subtypes Between German and Sudanese Women: A Facility-Based Cohort StudyAsmerom Tesfamariam SengalNada Suliman Haj MukhtarMartina VetterAhmed Mohammed ElhajShahinaz BedriSteffen HauptmannChristoph ThomssenAhmed Abdalla MohamedaniClaudia WickenhauserEva Johanna KantelhardtPurpose: The objective of this study was to compare tumor characteristics, biomarkers, and surrogate subtypes of breast cancer between Sudanese and German women. Methods: Tumor characteristics and immunohistochemistry markers (estrogen receptor [ER], progesterone receptor [PR], and human epidermal growth factor receptor 2 [HER2]) were collected from the routine assessment of consecutive patients with invasive breast cancer diagnosed from 2010 to 2015 (Gezira University Pathology Laboratory, Gezira, Sudan) and from 1999 to 2013 (Breast Centre, Martin-Luther-University, Halle, Germany). Results: A total of 2,492 patients (German [n = 1,932] and Sudanese [n = 560]) were included. Age at diagnosis ranged from 20 to 94 years. Sudanese women were, on average, 10 years younger than German women, with a mean (± standard deviation) age of 48.8 (13.5) and 58.6 (12.4) years, respectively. The Sudanese women had a higher grade, larger tumor, and more lymph node positivity compared with German women. ER-, PR-, and HER2-negative proportions were 55%, 61.8%, and 71.3%, respectively, for Sudanese women versus 22.7%, 32.3%, and 82.5%, respectively, for German women. The triple-negative subtype was more prevalent in Sudanese women (34.5%) than in German women (14.2%). The strongest factor associated with ER-negative disease was grade III (odds ratio, 19.6; 95% CI 11.6 to 33.4; P < .001). Sudanese patients were at higher risk for ER-negative breast cancer, with an odds ratio of 2.01 (P = .001; adjusted for age, size, nodal status, histologic type, and grade). Stratified by grade, the influence of origin was observed in grade I and grade II tumors, but not in grade III tumors. Conclusion: Sudanese women had more aggressive tumor characteristics and unfavorable prognostic biomarkers. After adjustment, Sudanese origin was still associated with hormone receptor–negative disease, especially in grade I and II tumors. These findings suggest differences in tumor biology among these ethnic groups.http://ascopubs.org/doi/10.1200/JGO.2017.010082
spellingShingle Asmerom Tesfamariam Sengal
Nada Suliman Haj Mukhtar
Martina Vetter
Ahmed Mohammed Elhaj
Shahinaz Bedri
Steffen Hauptmann
Christoph Thomssen
Ahmed Abdalla Mohamedani
Claudia Wickenhauser
Eva Johanna Kantelhardt
Comparison of Receptor-Defined Breast Cancer Subtypes Between German and Sudanese Women: A Facility-Based Cohort Study
Journal of Global Oncology
title Comparison of Receptor-Defined Breast Cancer Subtypes Between German and Sudanese Women: A Facility-Based Cohort Study
title_full Comparison of Receptor-Defined Breast Cancer Subtypes Between German and Sudanese Women: A Facility-Based Cohort Study
title_fullStr Comparison of Receptor-Defined Breast Cancer Subtypes Between German and Sudanese Women: A Facility-Based Cohort Study
title_full_unstemmed Comparison of Receptor-Defined Breast Cancer Subtypes Between German and Sudanese Women: A Facility-Based Cohort Study
title_short Comparison of Receptor-Defined Breast Cancer Subtypes Between German and Sudanese Women: A Facility-Based Cohort Study
title_sort comparison of receptor defined breast cancer subtypes between german and sudanese women a facility based cohort study
url http://ascopubs.org/doi/10.1200/JGO.2017.010082
work_keys_str_mv AT asmeromtesfamariamsengal comparisonofreceptordefinedbreastcancersubtypesbetweengermanandsudanesewomenafacilitybasedcohortstudy
AT nadasulimanhajmukhtar comparisonofreceptordefinedbreastcancersubtypesbetweengermanandsudanesewomenafacilitybasedcohortstudy
AT martinavetter comparisonofreceptordefinedbreastcancersubtypesbetweengermanandsudanesewomenafacilitybasedcohortstudy
AT ahmedmohammedelhaj comparisonofreceptordefinedbreastcancersubtypesbetweengermanandsudanesewomenafacilitybasedcohortstudy
AT shahinazbedri comparisonofreceptordefinedbreastcancersubtypesbetweengermanandsudanesewomenafacilitybasedcohortstudy
AT steffenhauptmann comparisonofreceptordefinedbreastcancersubtypesbetweengermanandsudanesewomenafacilitybasedcohortstudy
AT christophthomssen comparisonofreceptordefinedbreastcancersubtypesbetweengermanandsudanesewomenafacilitybasedcohortstudy
AT ahmedabdallamohamedani comparisonofreceptordefinedbreastcancersubtypesbetweengermanandsudanesewomenafacilitybasedcohortstudy
AT claudiawickenhauser comparisonofreceptordefinedbreastcancersubtypesbetweengermanandsudanesewomenafacilitybasedcohortstudy
AT evajohannakantelhardt comparisonofreceptordefinedbreastcancersubtypesbetweengermanandsudanesewomenafacilitybasedcohortstudy